Get the Stockscreener App
36.06
0.67%
-0.2446
Franklin Genomic Advancements Etf stock is traded at $36.06, with a volume of 2,895.
It is down -0.67% in the last 24 hours and up +2.48% over the past month.
See More
Previous Close:
$36.30
Open:
$36.13
24h Volume:
2,895
Relative Volume:
0.88
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-2.51%
1M Performance:
+2.48%
6M Performance:
+32.46%
1Y Performance:
+24.03%
1-Day Range:
$36.06
$36.23
1-Week Range:
$36.06
$37.13
52-Week Range:
$23.74
$38.11
Franklin Genomic Advancements Etf Stock (HELX) Company Profile
Name
Franklin Genomic Advancements Etf
Sector
Industry
Phone
-
Address
-
Compare HELX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HELX
Franklin Genomic Advancements Etf
|
36.06 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
333.25 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
676.47 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
677.50 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
259.72 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
609.11 | 124.43B | 0 | 0 | 0 | 0.00 |
Franklin Genomic Advancements Etf Stock (HELX) Latest News
Is Franklin Genomic Advancements ETF stock included in top ETFs2025 Big Picture & Fast Moving Stock Watchlists - Улправда
What downside risks could hit Franklin Genomic Advancements ETF stockWeekly Trade Recap & Daily Chart Pattern Signals - Newser
Trading Systems Reacting to (HELX) Volatility - news.stocktradersdaily.com
Can Franklin Genomic Advancements ETF stock attract ESG investmentsMarket Performance Summary & AI Enhanced Trade Execution Alerts - Newser
Is Franklin Genomic Advancements ETF stock vulnerable to rate hikesJuly 2025 Sector Moves & Weekly Chart Analysis and Trade Guides - Newser
Can Franklin Genomic Advancements ETF stock retain market dominance2025 Pullback Review & Reliable Price Breakout Alerts - Newser
EDGAR Filing Documents for 0001133228-25-012986 - SEC.gov
Healthcare ETFs Trounce Tech, Grab Billions As Big Money Flees Bubble Fears - Sahm
The Zacks Analyst Blog Highlights LLY, EPHE, BBC, HELX, XHS and SURI - sharewise.com
Best-Performing ETFs of Last Week: Healthcare Rules - sharewise.com
How Franklin Genomic Advancements Etf (HELX) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Inside the Recent Strength in Biotech ETFs - TradingView
Is Franklin Genomic Advancements ETF stock positioned for secular growthJuly 2025 Momentum & Short-Term High Return Strategies - newser.com
(HELX) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com
How Franklin Genomic Advancements ETF stock compares with tech leadersJuly 2025 Catalysts & Daily Risk Controlled Trade Plans - newser.com
Will Franklin Genomic Advancements ETF stock beat growth indexesMarket Weekly Review & Daily Stock Trend Watchlist - newser.com
Franklin Genomic Advancements Etf Stock (HELX) Financials Data
There is no financial data for Franklin Genomic Advancements Etf (HELX). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.06%
1.34%
Cap:
|
Volume (24h):